Literature DB >> 1763622

Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears.

R S Kimura1, K S Lee, C L Nye, J A Trehey.   

Abstract

Streptomycin was injected subcutaneously into guinea pigs (n = 12) with unilateral endolymphatic hydrops. In the unoperated ears, sensory cells were degenerated at the basal ends of all cochleas and to varying extents in the vestibular sense organs. Hydropic ears, in contrast, showed greater ototoxicity in the cochlear and saccular sensory cells, while the drug's effect on the utricular and cristae sensory cells was increased, but less remarkable. In another series of normal animals (n = 16), streptomycin was applied to a fenestra of the lateral semicircular canal. Sensory cells of all three canal cristae and utricular macula were degenerated frequently, but the sensory cells of the cochleas were rarely affected. The vestibular lesions resulting from the canal approach were greater than those produced by systemic injection. Comparison with a former gentamicin-lateral canal series revealed very little difference in action of the two drugs. However, in hydropic ears, gentamicin application to the lateral canal produced increased lesions in all sensory cells, particularly in the organ of Corti. Hydropic ears are vulnerable and a greater caution is needed in administering aminoglycosides by both the systemic and the canal route to patients with Meniere's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763622     DOI: 10.3109/00016489109100751

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.

Authors:  Philippe Junet; Alexandre Karkas; Georges Dumas; Jean Louis Quesada; Sébastien Schmerber
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-16       Impact factor: 2.503

2.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

3.  Changes in cytochemistry of sensory and nonsensory cells in gentamicin-treated cochleas.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

Review 4.  Ménière's disease.

Authors:  S N Merchant; S D Rauch; J B Nadol
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Evidence-based modification of intratympanic gentamicin injections in patients with intractable vertigo.

Authors:  Feng Zhai; Jian-Ping Liu; Chun-Fu Dai; Qi Wang; Peter S Steyger
Journal:  Otol Neurotol       Date:  2010-06       Impact factor: 2.311

6.  Gentamicin delivery to the inner ear: Does endolymphatic hydrops matter?

Authors:  Pedro Marques; Maoli Duan; Nicolas Perez-Fernandez; Jorge Spratley
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.